Luoyan Ai

1.2k total citations · 1 hit paper
23 papers, 837 citations indexed

About

Luoyan Ai is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Luoyan Ai has authored 23 papers receiving a total of 837 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Oncology and 5 papers in Epidemiology. Recurrent topics in Luoyan Ai's work include Cancer Immunotherapy and Biomarkers (5 papers), CAR-T cell therapy research (3 papers) and Gut microbiota and health (3 papers). Luoyan Ai is often cited by papers focused on Cancer Immunotherapy and Biomarkers (5 papers), CAR-T cell therapy research (3 papers) and Gut microbiota and health (3 papers). Luoyan Ai collaborates with scholars based in China, United States and Russia. Luoyan Ai's co-authors include Jie Xu, Antao Xu, Jing‐Yuan Fang, Zhaofei Chen, Jin Qian, Lunxi Liang, Yingxuan Chen, Yun Qian, Huimin Chen and Zhuping Fan and has published in prestigious journals such as Nature Communications, Cancer Research and Gut.

In The Last Decade

Luoyan Ai

21 papers receiving 826 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Roles of PD-1/PD-L1 Pathway: Signaling, Cancer, and Beyond

2020 362 citations Luoyan Ai, Antao Xu et al. Advances in experimental medicine and biology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Luoyan Ai China	12	397	371	220	122	119	23	837
Antao Xu China	8	231 0.6×	246 0.7×	210 1.0×	68 0.6×	112 0.9×	20	657
Hsiao‐Chi Tsai Taiwan	19	564 1.4×	275 0.7×	187 0.8×	246 2.0×	126 1.1×	31	1.0k
Zhonghua Chu China	17	461 1.2×	227 0.6×	207 0.9×	182 1.5×	69 0.6×	36	759
Zhiming Jin China	17	422 1.1×	309 0.8×	91 0.4×	169 1.4×	154 1.3×	24	781
Huaping Xiao China	13	208 0.5×	369 1.0×	433 2.0×	101 0.8×	88 0.7×	27	869
Jeong Won Choi South Korea	15	413 1.0×	142 0.4×	149 0.7×	146 1.2×	38 0.3×	41	841
Changdong Lin China	13	286 0.7×	153 0.4×	132 0.6×	68 0.6×	62 0.5×	24	546
Stephen M. Christensen United States	11	333 0.8×	158 0.4×	385 1.8×	110 0.9×	84 0.7×	14	955
Xinyu Shao China	11	333 0.8×	179 0.5×	61 0.3×	122 1.0×	70 0.6×	29	585

Countries citing papers authored by Luoyan Ai

Since Specialization

Citations

This map shows the geographic impact of Luoyan Ai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luoyan Ai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luoyan Ai more than expected).

Fields of papers citing papers by Luoyan Ai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luoyan Ai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luoyan Ai. The network helps show where Luoyan Ai may publish in the future.

Co-authorship network of co-authors of Luoyan Ai

This figure shows the co-authorship network connecting the top 25 collaborators of Luoyan Ai. A scholar is included among the top collaborators of Luoyan Ai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luoyan Ai. Luoyan Ai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Chi, Yanjing Zhu, Luoyan Ai, et al.. (2025). Targeting WEE1 in ARID1A/TP53 Concurrent Mutant Colorectal Cancer by Exploiting R‐Loop Accumulation and DNA Repair Deficiencies. Advanced Science. 13(9). e12074–e12074.

Zhang, Chi, Ke Peng, Qing Liu, et al.. (2025). Abstract 2908: WEE1 as a therapeutic target in TP53 and ARID1A concurrent mutant colorectal cancers. Cancer Research. 85(8_Supplement_1). 2908–2908. 1 indexed citations

Zhang, Shilong, Ning‐Ping Zhang, Jinyi Lin, et al.. (2025). Management of multisystemic irAEs associated with atezolizumab/tiragolumab combination therapy in a patient with lung adenocarcinoma: case report and review. 4(1).

Xu, Xiaojing, Luoyan Ai, Li Liang, et al.. (2024). Tislelizumab plus cetuximab and irinotecan in refractory microsatellite stable and RAS wild-type metastatic colorectal cancer: a single-arm phase 2 study. Nature Communications. 15(1). 7255–7255. 16 indexed citations

Xu, Xiaojing, Ke Peng, Xun Sun, et al.. (2022). Heparanase modulates the prognosis and development of BRAF V600E-mutant colorectal cancer by regulating AKT/p27Kip1/Cyclin E2 pathway. Oncogenesis. 11(1). 58–58. 5 indexed citations

Zhang, Shilong, Yan Wang, Pengfei Zhang, Luoyan Ai, & Tianshu Liu. (2022). Cardiovascular Outcomes in the Patients With Colorectal Cancer: A Multi-Registry-Based Cohort Study of 197,699 Cases in the Real World. Frontiers in Cardiovascular Medicine. 9. 851833–851833. 6 indexed citations

Liu, Zhongming, Xinxin Liu, Huiping Li, et al.. (2022). Preparation of composite micro-slag based on the application of tailings slag in cement and concrete. Construction and Building Materials. 322. 126515–126515. 14 indexed citations

Liu, Qing, Yiyi Yu, Jinyi Lin, et al.. (2021). Treatment strategy for myocarditis in patients using immune checkpoint inhibitors or combined anti-vascular endothelial growth factor therapy by clinical severity. European Journal of Cancer. 157. 10–20. 8 indexed citations

Ai, Luoyan, Mingming Zhu, Shiyuan Lu, et al.. (2021). Synbindin restrains proinflammatory macrophage activation against microbiota and mucosal inflammation during colitis. Gut. 70(12). 2261–2272. 42 indexed citations

10.

Qian, Yun, Luoyan Ai, Yile Xie, et al.. (2021). TRAPPC4 regulates the intracellular trafficking of PD-L1 and antitumor immunity. Nature Communications. 12(1). 5405–5405. 46 indexed citations

11.

Ai, Luoyan, Antao Xu, & Jie Xu. (2020). Roles of PD-1/PD-L1 Pathway: Signaling, Cancer, and Beyond. Advances in experimental medicine and biology. 1248. 33–59. 362 indexed citations breakdown →

12.

Zhang, Yanan, Renying Xu, Luoyan Ai, & Zhuping Fan. (2020). Association between non-alcoholic fatty liver disease and silent carotid plaque in Chinese aged population: a cross-sectional study. Annals of Palliative Medicine. 9(2). 182–189. 3 indexed citations

13.

Ai, Luoyan, Yiting Li, Haoyan Chen, et al.. (2018). Synbindin deficiency inhibits colon carcinogenesis by attenuating Wnt cascade and balancing gut microbiome. International Journal of Cancer. 145(1). 206–220. 11 indexed citations

14.

Wang, Xiaohan, Luoyan Ai, Qingqing Xu, et al.. (2017). A20 Attenuates Liver Fibrosis in NAFLD and Inhibits Inflammation Responses. Inflammation. 40(3). 840–848. 19 indexed citations

15.

Qian, Jin, Yueyuan Li, Han Yao, et al.. (2017). ASAP3 regulates microvilli structure in parietal cells and presents intervention target for gastric acidity. Signal Transduction and Targeted Therapy. 2(1). 17003–17003. 2 indexed citations

16.

Ai, Luoyan, Xiaohan Wang, Zhiwei Chen, et al.. (2016). A20 reduces lipid storage and inflammation in hypertrophic adipocytes via p38 and Akt signaling. Molecular and Cellular Biochemistry. 420(1-2). 73–83. 5 indexed citations

17.

Ai, Luoyan, Qingqing Xu, Changwei W. Wu, et al.. (2015). A20 Attenuates FFAs-induced Lipid Accumulation in Nonalcoholic Steatohepatitis. International Journal of Biological Sciences. 11(12). 1436–1446. 19 indexed citations

18.

Chen, Zhaofei, Luoyan Ai, Jilin Wang, et al.. (2015). Probiotics Clostridium Butyricum and Bacillus Subtilis Ameliorate Intestinal Tumorigenesis. Future Microbiology. 10(9). 1433–1445. 85 indexed citations

19.

Liang, Lunxi, Luoyan Ai, Jin Qian, Jing‐Yuan Fang, & Jie Xu. (2015). Long noncoding RNA expression profiles in gut tissues constitute molecular signatures that reflect the types of microbes. Scientific Reports. 5(1). 11763–11763. 74 indexed citations

20.

Chen, Zhiwei, Luoyan Ai, Changwei W. Wu, et al.. (2014). UGT1A1 sequence variants associated with risk of adult hyperbilirubinemia: A quantitative analysis. Gene. 552(1). 32–38. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact